Basel Medical Group (BMGL) Income Statement (2022 - 2025)
Annual Income Statement report data from Jun 30, 2022 to Jun 30, 2025 for Basel Medical Group (BMGL) in SGD with ability to convert in USD.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Revenue and COGS | ||||
Total Revenue | 11M (+12.64%) | 10M (+3.61%) | 9.70M (-9.01%) | 11M |
Cost Of Revenue | 2.53M (+12.44%) | 2.25M (-3.85%) | 2.34M (+7.34%) | 2.18M |
Costof Goods And Services Sold | 2.53M (+12.44%) | 2.25M (-3.85%) | 2.34M (+7.34%) | 2.18M |
Gross Profit | 8.79M (+12.69%) | 7.80M (+5.98%) | 7.36M (-13.21%) | 8.48M |
Operating Expenses | ||||
Selling General And Administrative | 6.54M (+79.67%) | 3.64M (+11.31%) | 3.27M (-19.06%) | 4.04M |
Operating Expenses | 11M (+95.72%) | 5.61M (+4.66%) | 5.36M (-10.82%) | 6.01M |
Depreciation And Amortization | 1.18M (+122.64%) | 530K (-5.36%) | 560K (-3.45%) | 580K |
Operating Income | ||||
Operating Income | -2.18M | 2.20M (+10.00%) | 2.00M (-19.03%) | 2.47M |
Ebit | -12.30M | 2.58M (+8.86%) | 2.37M (-12.55%) | 2.71M |
EBITDA | -11.12M | 3.11M (+6.14%) | 2.93M (-10.67%) | 3.28M |
Other Income / Expenses | ||||
Interest Income | 80K | - | 300K (+20.00%) | 250K |
Interest Expense | 200K (+11.11%) | 180K (-25.00%) | 240K (-25.00%) | 320K |
Net Interest Income | -120.00K (-33.33%) | -180.00K | 60K | -70.00K |
Net Income | ||||
Income Before Tax | -12.51M | 2.40M (+12.68%) | 2.13M (-10.88%) | 2.39M |
Income Tax Expense | -420.00K | 330K (-5.71%) | 350K (-14.63%) | 410K |
Net Income From Continuing Operations | -12.09M | 2.07M (+16.29%) | 1.78M (-10.10%) | 1.98M |
Net Income | -12.09M | 2.07M (+16.29%) | 1.78M (-10.10%) | 1.98M |